Nursing and Midwifery Council determination — substantive hearing
NMC suspends Michael Rotgans for twelve months over controlled-drug handling and dishonesty
The NMC imposed twelve months' suspension with review on Michael Rotgans, finding impairment on public-interest grounds only. Eight allegations were not proved.
MedicWatch editorial · Published 11 November 2026 · Updated 20 November 2026
Suspension (suspended from practice) — 1 year
Data last checked: 20 November 2026Report a correction
What does “suspended from practice” mean?
The regulator imposed a fixed-term suspension in this decision. Its start date, appeal provisions and any later review affect whether it is currently in force. Check the official register for the practitioner's current status.
Concerning Michael Rotgans, nurse (Nursing and Midwifery Council 02H0117O).
Decision date: 11 November 2026 · Hearing started 12 October 2026 and ended 11 November 2026
In plain English
The NMC found that Michael Rotgans mishandled controlled drugs and dishonestly failed to report a broken ampoule. It rejected eight allegations and found that two other proved allegations did not amount to misconduct. The panel found impaired fitness to practise on public-interest grounds only, identifying no present patient-safety risk. It imposed twelve months' suspension with review and a separate interim suspension during the appeal period.
Charges
The allegations concerned controlled-drug handling, labelling and disposal, reporting a broken midazolam ampoule, dishonesty and entries in a controlled-drugs register.
Findings
Charges 2.1,3.3,4.1,4.2,5.3 and 6 were proved, three by admission. Charges 1,2.2,3.1,3.2,5.1,5.2,7.1 and 7.2 were not proved. Proved charges 2.1 and 3.3 did not amount to misconduct. The panel found serious misconduct in 4.1,4.2,5.3 and 6 and impairment on public-interest grounds only, finding no past unwarranted patient harm or present patient risk. It imposed twelve months' suspension with review and a separate eighteen-month interim suspension for any appeal. Without appeal, the substantive suspension replaces the interim order 28 days after written notification. Private material remains protected.
Mitigating and aggravating factors
Mitigating factors
• [PRIVATE]. • At the time of the misconduct, your working environment was not ideal, in that you were working very long hours, away from home, travelling 400 miles a week, and working in a number of different remote units which could have impacted your situational awareness. Furthermore, staffing levels at the workplace had been changed from having 2 registered nurses per list to one which added significant pressure to the running of the list and in particular the management of controlled drugs. This was corroborated by colleagues during oral testimony. • Some admissions of the facts. • Developing insight. • Corporate sub-optimal management of expired controlled drugs providing latent conditions for error or misuse. • Key evidence at both the local investigation and the NMC case was the SWARM huddle. You were the only staff member present at this huddle from the day in question. Ideally all staff involved in an event must contribute to a huddle in order to gain a full understanding of facts. You were sent the transcript which you told management had inaccurately recorded the events but by that time you were suspended and no edits were made. This therefore meant key evidence was relied upon that was not a full factual record of the events under review. • Engaged with the local investigation. • During your submissions on sanctions, you were able to provide the panel with two examples of near misses and what you had learnt from the events. The panel considered that you showed a willingness to put things right and be open despite your employer knowing you were under investigation with the NMC, which demonstrated a principle of good practice. • Demonstrated integrity when disclosing the NMC proceedings to the New Zealand Nursing Council.
Aggravating factors
• Previous disciplinary findings – despite a final written warning which you had received in relation to your handling of controlled drugs, the panel determined that you failed to follow policy in relation to controlled drugs for the second time only weeks later, which indicates an attitudinal issue and lack of reflection and the ability to change practice • Repeated removal of controlled drugs without a second registered professional even after being admonished on the same day for exactly that conduct • Developing and fluctuating level of insight with regards to dishonesty • Deliberate breaches of the Code • Abuse of a position of trust
Source
All facts on this page are drawn from the publicly published Nursing and Midwifery Council determination linked below. MedicWatch does not editorialise the regulator’s findings.
Spot something incorrect?
If a fact on this page is wrong, or you believe the page should not be published, please submit a correction or takedown request.